Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add more filters










Database
Language
Publication year range
1.
Parasitol Res ; 88(2): 97-101, 2002 Feb.
Article in English | MEDLINE | ID: mdl-11936510

ABSTRACT

We report the ultrastructural alterations induced on epimastigotes by nifurtimox and 5-nitro-2-thienyl-malononitrile (5NO2TM), a novel compound with anti-Trypanosoma cruzi activity. Parasites treated with concentrations of nifurtimox lower than usually employed for this kind of study showed vacuolisation, alterations of the mitochondria, the nucleus and the ribosomes. 5NO2TM caused the same kind of damage, but to a greater degree. This result correlates with the fact that cultures treated with this compound experienced a greater loss of viability.


Subject(s)
Malonates/pharmacology , Nifurtimox/pharmacology , Nitriles/pharmacology , Trypanocidal Agents/pharmacology , Trypanosoma cruzi/drug effects , Trypanosoma cruzi/ultrastructure , Animals , Cells, Cultured , Life Cycle Stages , Malonates/metabolism , Malonates/toxicity , Mitochondria/drug effects , Nifurtimox/toxicity , Nitriles/metabolism , Nitriles/toxicity , Nitro Compounds/pharmacology , Nitro Compounds/toxicity , Parasitic Sensitivity Tests , Time Factors , Trypanocidal Agents/toxicity , Trypanosoma cruzi/growth & development
2.
Parasitol Res ; 87(8): 615-8, 2001 Aug.
Article in English | MEDLINE | ID: mdl-11510996

ABSTRACT

The effect of nifurtimox and 5-nitro-2-thienylmalononitrile (5NO2TM), a novel compound with anti-Trypanosoma cruzi activity, upon vitality and HSP60 immunoreactivity of epimastigotes, has been determined. Both products showed no activity against epimastigotes at 0.1 microg/ml, while at 0.5 and 1 microg/ml, after 24 h of incubation, densities of these groups were significantly reduced, when compared to controls. An enhancement of HSP60 immunoreactivity was observed after 24 h in groups treated with 0.5 and 1 microg/ml nifurtimox. On the other hand, 5NO2TM had no effect.


Subject(s)
Chaperonin 60/metabolism , Nifurtimox/pharmacology , Nitro Compounds/pharmacology , Trypanocidal Agents/pharmacology , Trypanosoma cruzi/drug effects , Animals , Chagas Disease/parasitology , Chaperonin 60/drug effects , Parasitic Sensitivity Tests/methods , Trypanosoma cruzi/growth & development , Trypanosoma cruzi/metabolism
3.
J Ethnopharmacol ; 71(1-2): 101-7, 2000 Jul.
Article in English | MEDLINE | ID: mdl-10904152

ABSTRACT

From the beginning of this decade and with the revival of the phytotherapy, biological research about immunomodulatory, anti-inflammatory and antiprotozoal effects of Central and South American plants have been in progress. Our objective was to determine the antiprotozoal activity of 79 extracts from different plant families, including Asteraceae, Araceae, Moraceae, Solanaceae, Rhamnaceae, Zingiberaceae, Leguminosae and Sapotaceae. Once matching with herbarium specimens authenticated the plants, selected parts were separated, dried carefully and reduced to powder. Most of the screened extracts were aqueous. Two protozoa with different metabolic pathways, Trypanosoma cruzi and Trichomonas vaginalis were used as experimental models. Trypanocidal activity of plants was assayed on epimastigote cultures in liver infusion tryptose (LIT). Anti-Trichomonas activity was determined over cultures of the parasite in Diamond medium. In both cases, microscopic counting of parasites, after their incubation in the presence of different concentrations of the crude extracts, were made in order to determine the cytocidal and cytostatic activities respect to control cultures. Of the nine extracts that showed antiprotozoal activity, those from Mikania cordifolia and Philodendron bipinnatifidum were then fractionated, and again, were assayed the organic and aqueous phases obtained.


Subject(s)
Antiprotozoal Agents/pharmacology , Plant Extracts/pharmacology , Trichomonas vaginalis/drug effects , Trypanocidal Agents/pharmacology , Trypanosoma cruzi/drug effects , Americas , Animals , Drug Evaluation, Preclinical , Trichomonas vaginalis/growth & development , Trypanosoma cruzi/growth & development
4.
Parasitol Res ; 86(12): 999-1002, 2000 Dec.
Article in English | MEDLINE | ID: mdl-11133116

ABSTRACT

The method most commonly used in screening of drugs for the treatment of Chagas' disease, microscopic counting of viable trypanosomes, is time-consuming, labor-intensive, and dependent on the observer. Although the tetrazolium dye [MTT; 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide] assay is comparatively quick and accurate, it requires careful attention in design as well as in interpretation of the results. Therefore, we examined under various conditions the sensitivity and specificity of the MTT assay versus microscopic counting for determination of the viability of Trypanosoma cruzi for drug-screening purposes. We tested different concentrations of MTT in phenazine methosulfate (PMS) against T. cruzi epimastigotes of the Y strain in different stages of logarithmic growth. In our model, in tests of benznidazole and nifurtimox the optimal concentration of MTT was 2.5 mg/ml of PMS and the optimal incubation period was 75 min. This method detected parasite concentrations of approx. 500,000 epimastigotes/ml (P<0.01), and the linear correlation between absorbance values and numbers of epimastigotes per milliliter was very strong (approx. R = 0.99). The present MTT assay results in faster determination of the activity of compounds, is more objective, and enables testing of several drugs simultaneously.


Subject(s)
Parasitic Sensitivity Tests/methods , Tetrazolium Salts/metabolism , Thiazoles/metabolism , Trypanosoma cruzi/growth & development , Animals , Colorimetry , Culture Media , Nifurtimox/pharmacology , Nitroimidazoles/pharmacology , Oxidation-Reduction , Sensitivity and Specificity , Trypanocidal Agents/pharmacology , Trypanosoma cruzi/drug effects , Trypanosoma cruzi/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL
...